V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019926 | 270014680 | 1.53 | 44.4 | Palliative (P) | 2014-04-02 | 2014-04-23 | PEMBROLIZUMAB | N | N | 270017436 | DOCETAXEL |
| 270019928 | 270014696 | 1.65 | null | Curative (C) | 2016-05-24 | 2016-05-24 | MELPHALAN | 02 | N | 270017496 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 270019929 | 270010076 | null | 93 | Curative (C) | 2017-08-27 | 2017-09-01 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 02 | N | 270017577 | CVP R |
| 270019930 | 270010097 | 1.74 | 85 | Curative (C) | 2019-08-09 | 2019-08-10 | Y-90 | 02 | null | 270017792 | IMATINIB |
| 270019931 | 270010100 | 1.67 | 82.1 | null | 2017-08-20 | 2017-08-29 | ICE | 02 | N | 270017821 | VINCRISTINE |
| 270019932 | 270014733 | null | null | Palliative (P) | 2012-02-03 | 2015-06-03 | CHOP - 21 days | N | null | 270018171 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270019933 | 270010140 | null | -1 | Curative (C) | 2018-01-29 | 2018-01-30 | Methotrexate intrathecal | 02 | N | 270018255 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270019934 | 270014738 | 1.7 | 59 | Curative (C) | 2018-04-01 | 2018-04-01 | RATHL TRIAL | 2 | N | 270018269 | ICE |
| 270019935 | 270010157 | 1.6 | 31 | null | null | 2018-01-20 | RATHL TRIAL | 2 | N | 270018427 | BREVITY TRIAL |
| 270019936 | 270010163 | null | 49 | null | null | 2017-08-09 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | N | N | 270018453 | DOXORUBICIN |
| 270019937 | 270010169 | 1.79 | 64.5 | Curative (C) | null | 2015-08-26 | DHAX | 2 | N | 270018521 | NILOTINIB |
| 270019938 | 270010205 | null | null | Curative (C) | null | 2014-05-05 | CHLVPP PABLOE | 99 | N | 270018829 | CVP R |
| 270019939 | 270010219 | 1.75 | 48.7 | Palliative (P) | 2016-12-03 | 2017-06-16 | DOXORUBICIN | N | N | 270018889 | ICE-R |
| 270019940 | 270010270 | 1.73 | 53.9 | null | 2015-02-15 | 2015-05-23 | Bortezomib + Cyclophos + Dex | N | N | 270019599 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 270019941 | 270010274 | 1.84 | 84.6 | Curative (C) | 2017-12-09 | 2017-12-19 | BLEOMYCIN | N | N | 270019601 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270019942 | 270017167 | 1.81 | 74.9 | Adjuvant (A) | 2019-08-22 | 2019-08-23 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 270019883 | PMITCEBOM-R |
| 270019943 | 270010323 | null | 73.2 | Palliative (P) | 2018-04-23 | 2018-05-06 | NHL 2003 Gp B COP | N | N | 270019995 | CVP R |
| 270019944 | 270010393 | 1.69 | 58 | Palliative (P) | 2014-11-06 | 2015-01-07 | R GCVP | N | N | 270020762 | GEMCARBO |
| 270019945 | 270014861 | 1.48 | 57 | null | 2018-11-17 | 2018-11-18 | CARBOPLATIN + CETUXIMAB + FU | 02 | N | 270021045 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270019946 | 270010444 | 1.71 | 80 | Disease modification (D) | 2017-01-07 | 2017-07-22 | TRASTUZUMAB | 02 | Y | 270021829 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270019947 | 270010517 | 1.57 | 71 | null | 2018-11-05 | 2018-11-09 | Hydroxycarbamide | 2 | N | 270022895 | GEMCARBO |
| 270019948 | 270010542 | 1.57 | 70.2 | Palliative (P) | 2018-08-03 | 2018-10-26 | DA 3 + 10 | N | N | 270023166 | CARBOPLATIN + RT |
| 270019949 | 270014930 | 1.63 | 65.9 | null | 2016-08-21 | 2016-10-28 | Carboplatin + Pemetrexed | Y | N | 270023353 | FLUOROURACIL + RT |
| 270019950 | 270010569 | null | 64.4 | Curative (C) | 2016-07-05 | 2016-07-05 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 02 | null | 270023443 | ETOPOSIDE |
| 270019951 | 270010736 | 1.54 | 76 | Curative (C) | 2018-09-24 | 2018-11-20 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 270025878 | GEMCITABINE + OXALIPLATIN |
| 270019952 | 270015032 | 1.78 | 63.3 | Not known (9) | 2018-04-04 | 2018-04-27 | Fludarabine + Melphalan RIC Allo | N | null | 270006274 | CAV |
| 270019953 | 270010813 | 1.75 | 59 | Curative (C) | 2016-11-03 | 2016-11-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 270010649 | FLUOROURACIL + RT |
| 270019954 | 270010820 | 1.9 | null | Disease modification (D) | null | 2017-05-27 | Carboplatin + Pemetrexed | 2 | N | 270013426 | DOXORUBICIN |
| 270019955 | 270010854 | 1.56 | 59.5 | Palliative (P) | 2019-05-27 | 2019-05-29 | CYCLO + RITUXIMAB + VINCRISTINE | 2 | N | 270019766 | MELPHALAN |
| 270019956 | 270015063 | null | 56.2 | Palliative (P) | null | 2019-01-17 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 270020461 | CAPECITABINE + CETUXIMAB + CISPLATIN |
| 270019957 | 270010868 | 1.83 | 70.9 | Palliative (P) | 2018-09-30 | 2018-10-04 | Capecitabine + Mitomycin | N | N | 270021311 | BENDAMUSTINE + RITUXIMAB |
| 270019958 | 270010873 | 1.8 | 49.4 | null | null | 2019-09-09 | CARBOPLATIN + RT | 2 | N | 270021755 | CARBOPLATIN + RT |
| 270019959 | 270015074 | null | 67.9 | Disease modification (D) | 2016-03-16 | 2016-03-16 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 270022687 | CARBOPLATIN + RT |
| 270019960 | 270010895 | null | 76 | Palliative (P) | 2016-12-11 | 2016-12-16 | SCOT TRIAL | N | N | 270023466 | IBRUTINIB |
| 270019961 | 270010900 | null | null | Curative (C) | 2018-02-01 | 2018-02-14 | Abiraterone | N | N | 270023795 | CARBO + FLUOROURACIL |
| 270019962 | 270010919 | 1.7 | 64 | Palliative (P) | 2018-03-08 | 2018-05-03 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | N | 270024838 | CISPLATIN + ETOPOSIDE |
| 270019963 | 270006449 | 1.79 | 55.7 | Curative (C) | 2013-10-17 | 2013-10-17 | ABVD | N | N | 270000005 | ABVD |
| 270019964 | 270006577 | 1.79 | 85.3 | Palliative (P) | 2017-11-10 | 2017-11-17 | Irinotecan + Modified De Gramont | 2 | N | 270000967 | IRINOTECAN + MDG |
| 270019966 | 270006896 | 1.73 | 106.5 | Palliative (P) | 2014-01-20 | 2014-12-16 | Irinotecan + Modified De Gramont | N | N | 270003495 | IRINOTECAN + MDG |
| 270019967 | 270006940 | 1.64 | 50.8 | Adjuvant (A) | 2016-05-11 | 2016-05-19 | FLUOROURACIL + IRINOTECAN | 02 | N | 270003773 | IRINOTECAN + MDG |
| 270019968 | 270006964 | 1.7 | null | Adjuvant (A) | 2018-04-26 | 2018-05-01 | Irinotecan + Modified De Gramont | null | N | 270003945 | IRINOTECAN + MDG |
| 270019969 | 270006972 | 1.81 | 88 | Adjuvant (A) | 2015-08-19 | 2015-08-31 | Oxaliplatin + Modified de Gramont | N | N | 270003964 | OXALIPLATIN + MDG |
| 270019970 | 270016231 | 1.82 | 67 | Palliative (P) | 2018-09-24 | 2018-09-30 | Irinotecan + Modified De Gramont | null | N | 270004415 | IRINOTECAN + MDG |
| 270019971 | 270007077 | null | 67.5 | Palliative (P) | 2019-05-07 | 2019-05-08 | FLUOROURACIL + OXALIPLATIN | 02 | N | 270005026 | OXALIPLATIN + MDG |
| 270019972 | 270007109 | 1.73 | 98 | Adjuvant (A) | 2019-04-01 | 2019-04-17 | Oxaliplatin + Modified de Gramont | 2 | N | 270005418 | OXALIPLATIN + MDG |
| 270019973 | 270007141 | null | 67.5 | Palliative (P) | 2017-03-30 | 2017-04-29 | Irinotecan + Modified De Gramont | N | N | 270005867 | IRINOTECAN + MDG |
| 270019974 | 270016301 | null | 58.35 | Palliative (P) | 2019-05-30 | 2019-06-05 | Oxaliplatin + Modified de Gramont | N | null | 270006848 | OXALIPLATIN + MDG |
| 270019975 | 270016315 | 1.73 | 62.6 | Palliative (P) | 2017-01-21 | 2017-07-22 | Irinotecan + Modified De Gramont | 2 | N | 270007439 | IRINOTECAN + MDG |
| 270019976 | 270007317 | 1.79 | 87.1 | Palliative (P) | 2017-12-12 | 2018-01-16 | FLUOROURACIL + OXALIPLATIN | N | null | 270007906 | OXALIPLATIN + MDG |
| 270019977 | 270007324 | 1.67 | 65 | Curative (C) | 2015-06-24 | 2015-06-24 | Capecitabine | N | N | 270007931 | CAPECITABINE |